WENDY MARTIN: Open Payments
NPI 1447301171 · OWINGSVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$562 in 30 payments from 9 companies in 2025. Trend: 2023 $74 · 2024 $103 · 2025 $562
Food & beverage: $562
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 4 | $101 |
| Lundbeck LLC | 5 | $86 |
| Indivior Inc. | 5 | $86 |
| Vanda Pharmaceuticals Inc. | 3 | $58 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $55 |
| Otsuka America Pharmaceutical, Inc. | 3 | $52 |
| Teva Pharmaceuticals USA, Inc. | 3 | $49 |
| ABBVIE INC. | 2 | $39 |
| Dexcom, Inc. | 2 | $35 |
Products named: REXULTI, ARISTADA, SUBLOCADE, HETLIOZ, CAPLYTA, AUSTEDO XR, VRAYLAR, Dexcom G6 Transmitter.
Industry payments across KY — which companies pay providers there.
